Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

3BQD

Doubling the Size of the Glucocorticoid Receptor Ligand Binding Pocket by Deacylcortivazol

Summary for 3BQD
Entry DOI10.2210/pdb3bqd/pdb
Related1M2Z
DescriptorGlucocorticoid receptor, Nuclear receptor coactivator 1, 1-[(1R,2R,3aS,3bS,10aR,10bS,11S,12aS)-1,11-dihydroxy-2,5,10a,12a-tetramethyl-7-phenyl-1,2,3,3a,3b,7,10,10a,10b,11,12,12a-dodecahydrocyclopenta[5,6]naphtho[1,2-f]indazol-1-yl]-2-hydroxyethanone, ... (4 entities in total)
Functional Keywordsglucocorticoid receptor, deacylcortivazol, src1, nuclear receptor coactivator 1 isoform 1, dimer interface, hormone binding pocket, charge clamp, coactivator, alternative initiation, alternative splicing, chromatin regulator, cytoplasm, disease mutation, dna-binding, lipid-binding, metal-binding, nucleus, phosphoprotein, polymorphism, pseudohermaphroditism, steroid-binding, transcription, transcription regulation, ubl conjugation, zinc, zinc-finger, acyltransferase, chromosomal rearrangement, proto-oncogene, transferase, protein binding
Biological sourceHomo sapiens (human)
More
Cellular locationCytoplasm. Isoform Beta: Nucleus: P04150
Nucleus (By similarity): Q15788
Total number of polymer chains2
Total formula weight31576.74
Authors
Xu, H.E. (deposition date: 2007-12-20, release date: 2008-01-15, Last modification date: 2023-08-30)
Primary citationSuino-Powell, K.,Xu, Y.,Zhang, C.,Tao, Y.G.,Tolbert, W.D.,Simons, S.S.,Xu, H.E.
Doubling the size of the glucocorticoid receptor ligand binding pocket by deacylcortivazol.
Mol.Cell.Biol., 28:1915-1923, 2008
Cited by
PubMed Abstract: A common feature of nuclear receptor ligand binding domains (LBD) is a helical sandwich fold that nests a ligand binding pocket within the bottom half of the domain. Here we report that the ligand pocket of glucocorticoid receptor (GR) can be continuously extended into the top half of the LBD by binding to deacylcortivazol (DAC), an extremely potent glucocorticoid. It has been puzzling for decades why DAC, which contains a phenylpyrazole replacement at the conserved 3-ketone of steroid hormones that are normally required for activation of their cognate receptors, is a potent GR activator. The crystal structure of the GR LBD bound to DAC and the fourth LXXLL motif of steroid receptor coactivator 1 reveals that the GR ligand binding pocket is expanded to a size of 1,070 A(3), effectively doubling the size of the GR dexamethasone-binding pocket of 540 A(3) and yet leaving the structure of the coactivator binding site intact. DAC occupies only approximately 50% of the space of the pocket but makes intricate interactions with the receptor around the phenylpyrazole group that accounts for the high-affinity binding of DAC. The dramatic expansion of the DAC-binding pocket thus highlights the conformational adaptability of GR to ligand binding. The new structure also allows docking of various nonsteroidal ligands that cannot be fitted into the previous structures, thus providing a new rational template for drug discovery of steroidal and nonsteroidal glucocorticoids that can be specifically designed to reach the unoccupied space of the expanded pocket.
PubMed: 18160712
DOI: 10.1128/MCB.01541-07
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.5 Å)
Structure validation

227344

數據於2024-11-13公開中

PDB statisticsPDBj update infoContact PDBjnumon